137 related articles for article (PubMed ID: 16370383)
21. New frontiers in cell-based immunotherapy of cancer.
D'Elios MM; Del Prete G; Amedei A
Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
[TBL] [Abstract][Full Text] [Related]
22. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Ambühl PM; Tissot AC; Fulurija A; Maurer P; Nussberger J; Sabat R; Nief V; Schellekens C; Sladko K; Roubicek K; Pfister T; Rettenbacher M; Volk HD; Wagner F; Müller P; Jennings GT; Bachmann MF
J Hypertens; 2007 Jan; 25(1):63-72. PubMed ID: 17143175
[TBL] [Abstract][Full Text] [Related]
23. Drug discovery. Magnificent obsession.
Couzin J
Science; 2005 Mar; 307(5716):1712-5. PubMed ID: 15774740
[No Abstract] [Full Text] [Related]
24. A clinical development paradigm for cancer vaccines and related biologics.
Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
[TBL] [Abstract][Full Text] [Related]
25. XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator.
van Eden W
Curr Opin Investig Drugs; 2008 May; 9(5):523-33. PubMed ID: 18465663
[TBL] [Abstract][Full Text] [Related]
26. Vaccines for the prevention of cardiovascular disease.
Ryan US; Rittershaus CW
Vascul Pharmacol; 2006 Nov; 45(5):253-7. PubMed ID: 17046334
[TBL] [Abstract][Full Text] [Related]
27. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer.
Tamm I
Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763
[TBL] [Abstract][Full Text] [Related]
28. Antigen-specific therapies in multiple sclerosis.
Giacomini PS; Bar-Or A
Expert Opin Emerg Drugs; 2009 Sep; 14(3):551-60. PubMed ID: 19708820
[TBL] [Abstract][Full Text] [Related]
29. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
Biggers K; Scheinfeld N
Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109
[TBL] [Abstract][Full Text] [Related]
30. Glatiramer in the treatment of multiple sclerosis.
Rizvi SA; Kim E; Moodie J
Int J Nanomedicine; 2006; 1(3):283-9. PubMed ID: 17717969
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal phototherapy in multiple sclerosis.
Comi G
Neurol Sci; 2006 Apr; 27(1):3-4. PubMed ID: 16688591
[No Abstract] [Full Text] [Related]
32. Vitamin D as an immune modulator in multiple sclerosis, a review.
Smolders J; Damoiseaux J; Menheere P; Hupperts R
J Neuroimmunol; 2008 Feb; 194(1-2):7-17. PubMed ID: 18177949
[TBL] [Abstract][Full Text] [Related]
33. Application of PCR technology in vaccine product development.
Wolf JJ; Wang L; Wang F
Expert Rev Vaccines; 2007 Aug; 6(4):547-58. PubMed ID: 17669009
[TBL] [Abstract][Full Text] [Related]
34. 1D09C3, an mAb specific for MHC-II.
Zola H; Beare A
Curr Opin Mol Ther; 2008 Feb; 10(1):68-74. PubMed ID: 18228184
[TBL] [Abstract][Full Text] [Related]
35. Clinical studies of experimental vaccines.
Bart PA; Harari A; Pantaleo G
Curr Opin HIV AIDS; 2006 Jul; 1(4):286-93. PubMed ID: 19372823
[TBL] [Abstract][Full Text] [Related]
36. Drug evaluation: sapacitabine--an orally available antimetabolite in the treatment of cancer.
Galmarini CM
Curr Opin Investig Drugs; 2006 Jun; 7(6):565-73. PubMed ID: 16784028
[TBL] [Abstract][Full Text] [Related]
37. Taranabant, a novel cannabinoid type 1 receptor inverse agonist.
Fremming BA; Boyd ST
Curr Opin Investig Drugs; 2008 Oct; 9(10):1116-29. PubMed ID: 18821475
[TBL] [Abstract][Full Text] [Related]
38. [The quest for an HIV vaccine].
Girard MP
Bull Acad Natl Med; 2005 May; 189(5):831-44; discussion 844. PubMed ID: 16433455
[TBL] [Abstract][Full Text] [Related]
39. Vaccine therapy in patients with renal cell carcinoma.
Van Poppel H; Joniau S; Van Gool SW
Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
[TBL] [Abstract][Full Text] [Related]
40. On the viral hypothesis of multiple sclerosis: participation of varicella-zoster virus.
Sotelo J
J Neurol Sci; 2007 Nov; 262(1-2):113-6. PubMed ID: 17663004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
